December 2026 Options Now Available For Innoviva (INVA)

A covered-call trade on Innoviva Inc. (INVA) is described: the stock trades at $19.69 and the Dec 2026 $20.00 call has a bid of $0.60. If assigned, the call seller would realize a 4.62% total return (excluding dividends and commissions); if the option expires worthless the collected premium represents a 3.05% one-time boost (3.09% annualized), and the analytics estimate a 40% chance of expiry worthless. Implied volatility on the call is 32% versus a 26% trailing 12‑month volatility, highlighting a modest options premium versus realized volatility.

Analysis

Market structure: The quoted Dec‑2026 $20 call (bid $0.60 on $19.69 stock) structurally benefits option sellers and yield-seeking equity holders who accept capped upside; covered‑call writers capture a gross 4.62% payoff if assigned and a 3.05% immediate yield boost if not. Market‑maker/flow dynamics matter — IV at 32% vs realized 26% (6pp premium) signals persistent demand for long protection or speculative convexity; dealers will delta‑hedge large option sales, amplifying short‑term stock moves around big flows.

Risk assessment: Tail risks are binary corporate events (royalty cadence changes, M&A or litigation) that could easily produce >20% moves before Dec‑2026; regulatory/contractual shocks could make long‑dated covered calls particularly costly. Timeframes differ: days–weeks driven by dealer hedging and news; months–quarters by earnings/royalty receipts; multi‑year by structural corporate action. Hidden dependencies include borrow/repo costs, dividend changes and liquidity in long‑dated options which can widen spreads and slippage.

Trade implications: With IV > realized, sell premium selectively: establish a 1–2% position in INVA and sell the Dec‑2026 $20 call (covered) to capture ~3–4% gross; use a hard stop if INVA < $17 (≈‑14%) or trim at $21 (take profit). If you prefer upside, buy a Dec‑2026 $20–$25 call spread (limit cost < $1.50) to keep upside while cutting premium; alternatively write cash‑secured Dec‑2026 $18 puts for similar yield if willing to own at that level.

Contrarian angles: Consensus treats the $20 strike as near‑term ceiling, but a material corporate catalyst (royalty reset or bid) could produce >25% upside making covered calls costly — this trade is underpriced insurance given 60% implied chance of finishing ITM. Historically, small royalty/holding companies have episodic M&A/value crystallization; cap your position size (<=2% portfolio) and watch IV/flow spikes which would reverse the attractiveness of short premium quickly.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in INVA at ~ $19.7 and sell-to-open the Dec‑2026 $20 covered call (collect $0.60). Target gross return 4.62% if called; set stop-loss to exit equity if price falls below $17 (≈14% drawdown) or trim position if stock > $21.
• If neutral and seeking income, sell a cash‑secured Dec‑2026 $18 put (size <=2% notional) to collect elevated premium driven by IV > realized; be willing to buy at $18 and cap downside risk with a 12–18 month reassessment plan.
• If bullish on a catalyst (expect >15% upside by Dec‑2026), buy a Dec‑2026 call spread (e.g., $20/$25) sized 0.5–1% portfolio to lever upside while limiting premium outlay; avoid naked long calls given theta and liquidity.
• Cap aggregate option‑writing exposure to INVA at 3% portfolio maximum due to concentrated tail risk; monitor IV vs realized spread—if IV narrows below realized (<=+2pp) or flows spike, unwind short positions within 7 trading days.